South Africa to Create State-Owned Pharma Firm
July 21, 2011
South Africa -- which has long complained of paying too much for the HIV drugs it distributes at state hospitals -- plans to set up a government-owned pharmaceutical company, a senior official said Tuesday. The ruling African National Congress made the decision over the weekend, said Gwede Mantashe, the party's general secretary. In an interview, Mantashe declined to give details but said there is a compelling argument for establishing such a firm, given that South Africa consumes one-quarter of the world's antiretrovirals. In December, health authorities announced that 10 manufacturers -- including South Africa's Aspen Phamacare and Adcock Ingram -- would share a contract worth 4.3 billion rand (US $615 million) to supply ARVs.
Transitioning Lead Responsibilities From U.S. to South Africa in the Countries' Partnership Against HIV/AIDS
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)